FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128102585> ?p ?o ?g. }

• W3128102585 endingPage "25" @default.
• W3128102585 startingPage "18" @default.
• W3128102585 abstract "PurposeAmong metastatic breast cancer (MBC) patients, those with a triple-negative breast cancer phenotype (mTNBC) have the worst prognosis, but the benefit of chemotherapy beyond second line on outcome remains uncertain. The purpose of this study was to identify predictive factors of outcome after third- or fourth-line chemotherapy.MethodsThe ESME-MBC database is a French prospective real-life cohort with homogeneous data collection, including patients who initiated first-line treatment for MBC (2008–2016) in 18 cancer centers. After selection of mTNBC cases, we searched for independent predictive factors (Cox proportional-hazards regression models) for overall survival (OS) on third- and fourth-line chemotherapy (OS3, OS4). We built prognostic nomograms based on the main prognostic factors identified.ResultsOf the 22,266 MBC cases in the ESME cohort, 2903 were mTNBC, 1074 (37%) and 598 (20%) of which had received at least 3 or 4 lines of chemotherapy. PFS after first- and second-line chemotherapy (PFS1, PFS2) and number of metastatic sites ≥3 at baseline were identified by multivariate analysis as prognostic factors for both OS3 (HR = 0.76 95%CI[0.66–0.88], HR = 0.55 95%CI[0.46–0.65], HR = 1.36 95%CI[1.14–1.62], respectively), and OS4 (HR = 0.76 95%CI[0.63–0.91], HR = 0.56 95%CI[0.45–0.7], HR = 1.37 95%CI[1.07–1.74]), respectively. In addition, metastasis-free interval was identified as a prognostic factor for OS3 (p = 0.01), while PFS3 influenced OS4 (HR = 0.75 95%CI[0.57–0.98]). Nomograms predicting OS3 and OS4 achieved a C-index of 0.62 and 0.61, respectively.ConclusionThe duration of each previous PFS is a major prognostic factor for OS in mTNBC patients receiving third- or fourth-line chemotherapy. The clinical utility of nomograms including this information was not demonstrated." @default.
• W3128102585 created "2021-02-15" @default.
• W3128102585 creator A5002141045 @default.
• W3128102585 creator A5003152750 @default.
• W3128102585 creator A5009030272 @default.
• W3128102585 creator A5014016532 @default.
• W3128102585 creator A5014921747 @default.
• W3128102585 creator A5016043294 @default.
• W3128102585 creator A5023675047 @default.
• W3128102585 creator A5041410352 @default.
• W3128102585 creator A5044769561 @default.
• W3128102585 creator A5049369439 @default.
• W3128102585 creator A5053668514 @default.
• W3128102585 creator A5056961294 @default.
• W3128102585 creator A5058791215 @default.
• W3128102585 creator A5060909413 @default.
• W3128102585 creator A5067379430 @default.
• W3128102585 creator A5067519332 @default.
• W3128102585 creator A5069540694 @default.
• W3128102585 creator A5071553983 @default.
• W3128102585 creator A5072048250 @default.
• W3128102585 creator A5073954292 @default.
• W3128102585 creator A5077643246 @default.
• W3128102585 creator A5084631227 @default.
• W3128102585 creator A5085324944 @default.
• W3128102585 date "2021-04-01" @default.
• W3128102585 modified "2023-10-05" @default.
• W3128102585 title "Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program" @default.
• W3128102585 cites W2029372507 @default.
• W3128102585 cites W2051989799 @default.
• W3128102585 cites W2059286998 @default.
• W3128102585 cites W2066165300 @default.
• W3128102585 cites W2069334578 @default.
• W3128102585 cites W2116356654 @default.
• W3128102585 cites W2120676861 @default.
• W3128102585 cites W2127152525 @default.
• W3128102585 cites W2137831643 @default.
• W3128102585 cites W2152035198 @default.
• W3128102585 cites W2168617295 @default.
• W3128102585 cites W2171057065 @default.
• W3128102585 cites W2782927180 @default.
• W3128102585 cites W2796557635 @default.
• W3128102585 cites W2897422388 @default.
• W3128102585 cites W2917655541 @default.
• W3128102585 cites W2917837889 @default.
• W3128102585 cites W2945716039 @default.
• W3128102585 cites W3088810176 @default.
• W3128102585 cites W3109853980 @default.
• W3128102585 cites W4239051461 @default.
• W3128102585 doi "https://doi.org/10.1016/j.breast.2021.01.006" @default.
• W3128102585 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7873471" @default.
• W3128102585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33561617" @default.
• W3128102585 hasPublicationYear "2021" @default.
• W3128102585 type Work @default.
• W3128102585 sameAs 3128102585 @default.
• W3128102585 citedByCount "1" @default.
• W3128102585 countsByYear W31281025852023 @default.
• W3128102585 crossrefType "journal-article" @default.
• W3128102585 hasAuthorship W3128102585A5002141045 @default.
• W3128102585 hasAuthorship W3128102585A5003152750 @default.
• W3128102585 hasAuthorship W3128102585A5009030272 @default.
• W3128102585 hasAuthorship W3128102585A5014016532 @default.
• W3128102585 hasAuthorship W3128102585A5014921747 @default.
• W3128102585 hasAuthorship W3128102585A5016043294 @default.
• W3128102585 hasAuthorship W3128102585A5023675047 @default.
• W3128102585 hasAuthorship W3128102585A5041410352 @default.
• W3128102585 hasAuthorship W3128102585A5044769561 @default.
• W3128102585 hasAuthorship W3128102585A5049369439 @default.
• W3128102585 hasAuthorship W3128102585A5053668514 @default.
• W3128102585 hasAuthorship W3128102585A5056961294 @default.
• W3128102585 hasAuthorship W3128102585A5058791215 @default.
• W3128102585 hasAuthorship W3128102585A5060909413 @default.
• W3128102585 hasAuthorship W3128102585A5067379430 @default.
• W3128102585 hasAuthorship W3128102585A5067519332 @default.
• W3128102585 hasAuthorship W3128102585A5069540694 @default.
• W3128102585 hasAuthorship W3128102585A5071553983 @default.
• W3128102585 hasAuthorship W3128102585A5072048250 @default.
• W3128102585 hasAuthorship W3128102585A5073954292 @default.
• W3128102585 hasAuthorship W3128102585A5077643246 @default.
• W3128102585 hasAuthorship W3128102585A5084631227 @default.
• W3128102585 hasAuthorship W3128102585A5085324944 @default.
• W3128102585 hasBestOaLocation W31281025851 @default.
• W3128102585 hasConcept C121608353 @default.
• W3128102585 hasConcept C126322002 @default.
• W3128102585 hasConcept C143998085 @default.
• W3128102585 hasConcept C188816634 @default.
• W3128102585 hasConcept C2775930923 @default.
• W3128102585 hasConcept C2776694085 @default.
• W3128102585 hasConcept C2779013556 @default.
• W3128102585 hasConcept C2780110267 @default.
• W3128102585 hasConcept C34626388 @default.
• W3128102585 hasConcept C38180746 @default.
• W3128102585 hasConcept C50382708 @default.
• W3128102585 hasConcept C530470458 @default.
• W3128102585 hasConcept C71924100 @default.
• W3128102585 hasConcept C72563966 @default.
• W3128102585 hasConceptScore W3128102585C121608353 @default.
• W3128102585 hasConceptScore W3128102585C126322002 @default.

• next